CATIE

Canada’s top doctors say Undetectable = Untransmittable

published: December, 04, 2017 Written by // Guest Authors - Revolving Door Categories // Activism, Social Media, As Prevention , CATIE, Current Affairs, Treatment Guidelines -including when to start, Research, Sexual Health, Health, Revolving Door, Treatment, Guest Authors, Media

CATIE Executive Director Laurie Edmiston on the November 30 joint statement from Canada’s chief public health officer and the chief medical officers of health of all Canadian provinces and territories.

Canada’s top doctors say Undetectable = Untransmittable

It’s official! The Government of Canada supports U=U, the consensus statement that a person living with HIV does not transmit the virus sexually if they take treatment and maintain an undetectable viral load (“undetectable = untransmittable”). The news came on November 30 in a joint statement from Canada’s chief public health officer and the chief medical officers of health of all Canadian provinces and territories. “We have known for some time that ART [antiretroviral therapy] i

It’s time to retire Canada’s AIDS epidemic

published: December, 01, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , CATIE, General Health, Treatment Guidelines -including when to start, Mental Health, Research, Health, CATIE - HIV and Hep C Info Resource, Revolving Door, Treatment, Guest Authors, Media, Opinion Pieces

For World AIDS Day 2017, PositiveLite.com is proud to present this guest editorial by CATIE Executive Director, Laurie Edmiston.

It’s time to retire Canada’s AIDS epidemic

Having turned 60 two months ago, I know there’s nothing quite like a milestone birthday to force you to get serious about your priorities and your future. The HIV response is facing our own wake-up call this December 1 as we mark the 30thWorld AIDS Day – a milestone I never imagined we would reach when I started working in HIV, 30 years ago. I have spent more than half of my life working in the HIV response, and while our goals have remained unchanged – reducing HIV infections and kee

CATIE scores again with a fine national conference – but is it their last?

published: November, 28, 2017 Written by // Bob Leahy - Publisher Categories // Social Media, African, Caribbean and Black, Gay Men, As Prevention , CATIE, Conferences, Current Affairs, Treatment Guidelines -including when to start, Events, Women, Health, CATIE - HIV and Hep C Info Resource, Treatment, Media, Bob Leahy - Publisher

Last week saw 400 people gather in Toronto for CATIE’s “Transforming our Practice” national forum, looking at new knowledge and new strategies to end the epidemic. It was an unqualified success. But what’s next? Bob Leahy reports.

CATIE scores again with a fine national conference – but is it their last?

I’m fortunate to attend many HIV conferences in Canada and sometimes elsewhere. They educate, they inspire and they allow for lots of networking – in particular the peer-to-peer engagement that so strengthens our response to HIV in Canada. CATIE delivered all of this last week in Toronto. While scholarships, through diminishing dollars continue to be hard to get, a sizeable contingent of people living with HIV were in the house, thanks in part to a financial arrangement with CATIE and the

What’s next for long-acting HIV drugs?

published: November, 22, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // As Prevention , CATIE, Current Affairs, Treatment Guidelines -including when to start, Research, CATIE - HIV and Hep C Info Resource, Health, Treatment

Two phase III trials are underway with long-acting (LA) formulations of HIV drugs. From CATIE, Sean R. Hosein reports.

What’s next for long-acting HIV drugs?

Two phase III trials are underway with long-acting (LA) formulations of HIV drugs. These trials will explore the safety and effectiveness of LA formulations in people new to HIV treatment (Flair) and in people who are treatment experienced (Atlas). The interim results from these two pivotal studies should be available in the latter half of 2018. If the results from Flair and Atlas are favourable, the manufacturer of the LA drugs, Viiv Healthcare, will submit a dossier of the data to regulator

World AIDS Day: Clients can handle the truth

published: November, 16, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Activism, Social Media, African, Caribbean and Black, CATIE, As Prevention , Gay Men, General Health, Current Affairs, Mental Health, Treatment Guidelines -including when to start, Research, Women, CATIE - HIV and Hep C Info Resource, Sexual Health, Health, Treatment, Media

CATIE: "Whether we are talking about U=U, PrEP or HIV self-testing, we must provide all the information and options to our clients, and trust them to make the best decisions for their own health."

World AIDS Day: Clients can handle the truth

Thousands of HIV organizations around the world are adding a new message to their World AIDS Day campaigns this year, and it is turning decades of HIV prevention messaging on its head. We can now say conclusively that a person living with HIV who takes treatment and maintains an undetectable viral load does not transmit the virus to their sexual partners. The evidence was solidified last year with the final results of PARTNER and HPTN 052, two large studies confirming zero cases of HIV transm

Investigating where patients go when they leave HIV care

published: November, 06, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, CATIE, As Prevention , General Health, Treatment Guidelines -including when to start, Research, Sexual Health, International , Treatment, Living with HIV, Media

From CATIE, Sean R. Hosein reports on research that begins to paint a picture of what happens when people living with HIV are "lost to follow-up."

Investigating where patients go when they leave HIV care

- Previous research has found HIV-positive Canadians stop attending follow-up HIV appointments at rates between 11% and 24%. - Alberta researchers find that many patients “lost to follow-up” are seeking healthcare outside HIV services, often in hospital emergency rooms. - This research has implications for programs that seek to re-engage patients in HIV care. Potent combination anti-HIV therapy (ART) can reduce levels of HIV in the blood (viral load) to very low levels that cannot be de

U.S. simulation explores the intersection of PrEP and some sexually transmitted infections

published: October, 10, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, CATIE, As Prevention , Gay Men, General Health, Treatment Guidelines -including when to start, Research, Health, CATIE - HIV and Hep C Info Resource, Sexual Health, Treatment, Lifestyle, Media

"The results of the researchers’ simulations show that PrEP should be considered as a package of interventions, of which STI screening and treatment are an important part. From Catie, Sean R. Hosein reports.

U.S. simulation explores the intersection of PrEP and some sexually transmitted infections

The use of medicines to prevent a person from becoming infected with HIV is called pre-exposure prophylaxis (PrEP). PrEP consists of two anti-HIV drugs—tenofovir DF and FTC—in one pill. In clinical trials with gay, bisexual and other men who have sex with men (MSM), PrEP has been highly effective in preventing the spread of HIV. According to a team of U.S. researchers who analysed data from several clinical trials, the consistent use of PrEP can reduce the risk of HIV infection “by more

Supervised injection facilities in Canada: past present and future

published: September, 26, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, CATIE, General Health, Current Affairs, CATIE - HIV and Hep C Info Resource, Health, Media

There has been an escalation of efforts to open new sites across Canada, spurred on by the ongoing opioid overdose epidemic.. From CATIE, Zak Knowles provides this overview.

Supervised injection facilities in Canada: past present and future

The current opioid epidemic in Canada has led to an increased understanding of the health-related and social harms associated with injection drug use. There is growing acceptance of the need for supervised injection facilities (SIFs) to help reduce these harms and the number of overdose deaths. A recent review1 looks at the history and future of SIFs in Canada and the impact of peers in the history and future of SIFs. SIFs in Vancouver In the mid to late 1990s, Vancouver’s health authorit

Frailty, nerve injury and falls in middle-aged and older HIV-positive people

published: September, 15, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Aging, Social Media, CATIE, General Health, Mental Health, Research, CATIE - HIV and Hep C Info Resource, International , Living with HIV, Media

From CATIE, Sean R. Hosein reports on a U.S. study that links such things as grip strength and gait speed with increased risk of falling.

Frailty, nerve injury and falls in middle-aged and older HIV-positive people

More HIV-positive people are living longer thanks to the use of potent combination anti-HIV therapy (ART). As HIV-positive people enter their middle age and senior years, they will have to grapple with one or more aging-related issues. One issue that can have a large impact on the health and quality of life of older people is falling. Older people who fall can injure themselves, and according to U.S. researchers, such injuries can make pre-existing problems, such as physical inactivity or weak

Ontario researchers find heart attacks occur earlier in people with HIV.

published: September, 12, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, CATIE, Research, Fitness and Exercise, Health, Media

The researchers found that, on average, HIV-positive people tended to have a heart attack about 15 years before HIV-negative people. From CATIE, Sean R. Hosein reports on the CIHR HIV Trials Network Trial - Reprieve Study.

Ontario researchers find heart attacks occur earlier in people with HIV.

Studies have found that some HIV-positive people are at heightened risk for cardiovascular disease. The reasons for this are not clear but may be due to one or more of the following factors: smoking and/or other substance use elevated inflammation caused by HIV the presence of co-existing health conditions such as elevated blood pressure, type 2 diabetes, obesity exposure to older HIV medicines A number of studies from the U.S. have found that HIV-positive people who had a heart attac

Hepatitis C: A silent killer and story that deserves more attention

published: July, 28, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Hep B and C, CATIE, General Health, Health, CATIE - HIV and Hep C Info Resource, Media

From CATIE on the occasion of World Hepatitis Day (July 28), this report on the current state of the fight against Hepatitis C in Canada.

Hepatitis C: A silent killer and story that deserves more attention

Hepatitis C is a silent killer (people can have it for decades without any symptoms) and a story that is not commonly known in Canada. Yet this virus affects many people, highlights inequities in our health and social systems and is part of an important Canadian story. Canada has a history of being on the forefront of addressing hepatitis C, starting with Dr. Michael Houghton, an internationally recognized microbiologist at the University of Alberta, who was the first to co-discover hepatitis

Webinar: preventing suicide among gay and bisexual men, Tuesday May 30th 10:00am PST

published: May, 15, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Gay Men, CATIE, Mental Health, Upcoming Events, Health, CATIE - HIV and Hep C Info Resource, Living with HIV, Media

Presented by CATIE and The Network: BC's gbMSM Health Resource.

Webinar: preventing suicide among gay and bisexual men, Tuesday May 30th 10:00am PST

Partners and Collaborators: Register Here! Suicide is the ninth leading cause of death among Canadians, responsible for nearly 4000 deaths each year. While everyone is susceptible to the feelings of hopelessness and despair that precede suicide, gay and bisexual men are 4 times more likely to attempt suicide in their lifetime than heterosexual men. Moreover, the suicide rate among gay and bisexual men in Canada is comparable to the current death toll from HIV/AIDS.  Suicide is preventable.

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

published: May, 02, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, Research, Health, CATIE - HIV and Hep C Info Resource, Treatment

Sean R. Hosein of CATIE reports on research in Vancouver that attempted to study the relative impact that ART, harm reduction or both can have on the spread of HIV.

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

In clinical trials, the early initiation of HIV treatment (ART) stabilizes the immune system and significantly reduces the risk of developing AIDS-related infections and cancers. This benefit of ART is so profound that researchers increasingly expect that many ART users will live into their senior years. Key to reaping the benefit of ART is achieving an undetectable level of HIV in the blood (viral load) and maintaining it through daily use of ART and regular checkups and laboratory monitori

CATIE joins in mourning the death of a brilliant scientist and friend – Professor Dr. Mark Wainberg

published: April, 14, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Activism, CATIE, As Prevention , General Health, Current Affairs, Treatment Guidelines -including when to start, Health, CATIE - HIV and Hep C Info Resource, Treatment, Media

Those of us in Canada and around the globe who struggle to end the HIV epidemic have lost a friend, mentor and key ally.

CATIE joins in mourning the death of a brilliant scientist and friend – Professor Dr. Mark Wainberg

Dr. Mark Wainberg passed away suddenly earlier this week. He was a brilliant scientist who helped to greatly extend our understanding about HIV and how this virus can develop resistance to treatment.  Dr. Wainberg’s career was centred at McGill University where he was the Director of the McGill AIDS Centre.  He became internationally renowned for the impact that his laboratory had on HIV treatment, as well as for the global impact of his efforts to help make HIV treatment more accessible.

The capsid inhibitor—a new class to enter clinical trials

published: April, 13, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, African, Caribbean and Black, CATIE, As Prevention , Gay Men, Youth, General Health, Treatment Guidelines -including when to start, Women, Sexual Health, Health, CATIE - HIV and Hep C Info Resource, International , Treatment, Media

From CATIE: "This finding suggests that the capsid inhibitor has potential for intermittent dosing in people—perhaps every one or two months."

The capsid inhibitor—a new class to enter clinical trials

Most approved anti-HIV drugs work by interfering with an enzyme and/or protein that is needed by HIV-infected cells to make new viruses. A journey through the cell The capsid is the name given to the proteins that surround HIV’s genetic material. Upon HIV attaching itself to a target cell of the immune system, the virus sends its genetic material (RNA) into the cell. As the genetic material is surrounded by the capsid, it is protected from detection by the cell’s internal sensors. The ca

[12 3 4 5  >>